Dr. Gerard Blobe, M.D., Ph.D., Joins Vivacitas Oncology’s Solid Tumor Medical Advisory Board
Vivacitas Oncology, Inc., a privately-held oncology company focused on tough-to-treat cancers, proudly announces that Dr. Gerard Blobe,
Vivacitas Oncology to Present at the 2022 BIO CEO & Investor Conference
Post Views: 266 Vivacitas Oncology, Inc., a privately-held biopharmaceutical company focused on tough-to-treat cancers, will present at the upcoming 2022 BIO CEO & Investor Conference, which will be held in New York City on February 14-17, 2022. Hosted by the Biotechnology Innovation Organization (BIO) for over 20 years, the annual event is focused on emerging…
